Therapy of hepatitis C in thalassemia: the influence of iron on achieving sustained viral response.
Alavian
Seyed-Moayed
SM
Tabatabaei
Seyed-Vahid
SV
D000998:Antiviral Agents / Q000627:therapeutic use; D006526:Hepatitis C / Q000097:blood* / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007501:Iron / Q000097:blood* / Q000378:metabolism*; D012254:Ribavirin / Q000627:therapeutic use; D013789:Thalassemia / Q000188:drug therapy / Q000821:virology*
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons; D007501:Iron